Digital Therapeutics

To be launched February 2025
Dr. Alex Sverdlov
Novartis Pharmaceuticals Corporation, USA
Summary

This lecture series is intended to provide a description and explanation of the field of digital therapeutics. It will consist of approximately 15 talks covering strategic, scientific, clinical, business, and regulatory aspects of DTx.